UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 6-K
 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
April 28, 2016
 
Commission File Number: 001-31368
 

SANOFI
(Translation of registrant’s name into English)
 

54, rue La Boétie, 75008 Paris, FRANCE
(Address of principal executive offices)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes ☐ No ☒
 
If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-  
 


On April 28, 2016, Sanofi issued the press release attached hereto as Exhibit 99.1, which is incorporated herein by reference.
 
Exhibit List
 
Exhibit
No.
 
 
Description
     
Exhibit 99.1
 
Press release issued by Sanofi dated April 28, 2016.
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Dated: April 28, 2016
SANOFI
     
 
By
/s/ Karen Linehan
 
Name:
Karen Linehan
 
Title:
Executive Vice President, Legal Affairs and General Counsel
 

Exhibit Index
 
Exhibit
No.
 
 
Description
     
 
Press release issued by Sanofi dated April 28, 2016.